Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(11 sites)
United States
Retina Macula Institute of AZ, Scottsdale, Arizona The Retina Partners, Encino, California Retinal Consultants Medical Group, Sacramento, California Retina Consultants San Diego, San Diego, California Star Retina, Burleson, Texas Retina Center of Texas, Southlake, Texas University of Utah John A. Moran Eye Center, Salt Lake City, Utah Australia
Sydney Retina Clinic and Day Surgery, Sydney, New South Wales Cerulea Clinical Trials, East Melbourne, Victoria Israel
Rambam Medical Center, Haifa Tel-Aviv Sourasky Medical Center, Ophthalmology Division, Tel Aviv